DiscoverTime Sink#242: Depends on How Many Eyes You Rip Out
#242: Depends on How Many Eyes You Rip Out

#242: Depends on How Many Eyes You Rip Out

Update: 2025-07-11
Share

Description

Ozempic holding an economy hostage, Denmark potentially following in Finland’s footsteps, and Hamza’s “Sus” topic, all this and more on this week’s visit to the Time Sink!


Show Notes:

Ozempic

Wegovy

Novo Nordisk

FDA Approval

Market Share

Novo Nordisk 2024 Annual Report

NPR Article

Largest European Companies (by revenue)

Semaglutide

Eyestalk Ablation

Horseshoe Crab Use in Medicine

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#242: Depends on How Many Eyes You Rip Out

#242: Depends on How Many Eyes You Rip Out

TimeSink